|
| Analyst
Scorecard | | Analyst: | Nash, Edward | EPS
Est. Accuracy: | Not Avl.
| | Broker: | Merriman Curhan Ford & Co. | Recommendation
Performance: | Not Avl.
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
Industry Coverage
| | |
Industry
|
EPS Est. Accuracy
|
Industry Excess Return
|
Industry Return
| | | |
Biotechnology
| 
| Not Avl.
| Not Avl.
| | | |
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
ANDS
|
Anadys Pharmaceuticals Inc
|
|
11
| | | | |
CBST
|
Cubist Pharmaceuticals Inc
|
|
12
| | | | |
CPRX
|
Catalyst Pharmaceutical Partners
|
|
3
| | | | |
GILD
|
Gilead Sciences Inc
|
|
22
| | | | |
RDEA
|
Ardea Biosciences Inc
|
|
7
| | | | |
VRTX
|
Vertex Pharmaceuticals Inc
| 
|
22
| | | | |
VRUS
|
Pharmasset Inc
|
|
9
| | | |
| Other Stocks Covered
| |
Achillion Pharmaceuticals Inc (ACHN), Halozyme Therapeutics Inc (HALO), Intermune Inc. (ITMN), Novavax Inc (NVAX), Polymedix Inc (PYMX.OB), Salix Pharmaceuticals Ltd (SLXP)
|
| | |
|
|
|
